Physician profile
Mohan Jacob
NPI 1942267448
$1,184.99
in general payments reported to CMS, 2019-2025
8 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $242 · 2021: $171 · 2022: $21.70 · 2023: $144 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $273.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $575.51 | 2019-2025 | Amvia Edge, Acticor 7 Vr-T Dx |
| Abbott Laboratories | $437.67 | 2019-2023 | Aveir |
| Janssen Pharmaceuticals, INC | $68.01 | 2019-2021 | |
| Amarin Pharma, INC. | $26.56 | 2019-2020 | |
| Pfizer INC. | $25.30 | 2019 | |
| Merck Sharp & Dohme LLC | $21.70 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.07 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohan Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.